Department of CTVS, Dayanand Medical College and Hospital, Ludhiana, Punjab, India.
Department of Cardiac Anaesthesia, Hero DMC Heart Institute, Ludhiana, Punjab, India.
Ann Card Anaesth. 2022 Apr-Jun;25(2):171-177. doi: 10.4103/aca.aca_22_22.
Veno-arterial extracorporeal membrane oxygenation (ECMO) is well-recognized treatment modality for patients with refractory cardiogenic shock. Uncomplicated cannulation is a prerequisite and basis for achieving a successful outcome in ECMO. Vascular access is obtained either by surgical cut-down. Common vascular access complications are bleeding and limb ischemia.
To evaluate cannulation technique, the incidence of vascular complications, and their impact on the outcome.
A retrospective data analysis conducted on 95 patients receiving ECMO from 2013 to 2020 was done. The patients were divided into two groups: no vascular access complications (non-VAC group) and vascular access complications (VAC group). The groups were compared related to the hospital and ICU stays and blood transfusion.
The patients in both groups were demographically and clinically comparable. The Non-VAC group had 75 patients, whereas the VAC group had a total of 20 patients. The main complication observed in the VAC group was bleeding from the cannulation site which required more blood transfusion than the non-VAC group (6.8 ± 1.02 vs 4.2 ± 1.26). Limb ischemia was another complication seen in the VAC group (4.2%, n = 4). Two patients had delayed bleeding after decannulation. The overall average length of stay in the hospital was statistically similar in both the groups (22 days in the VAC group vs 18 days in the non-VAC group), but the average ICU stay was more in the VAC group compared to the non-VAC group (18 days vs 12.06 days).
Bleeding and limb ischemia are the important vascular access site complications, which increase blood transfusion requirements, ICU stay, and overall hospital stay.
静脉-动脉体外膜肺氧合(ECMO)是治疗难治性心源性休克患者的有效治疗方法。简单的置管是 ECMO 成功的前提和基础。血管通路可以通过外科切开获得。常见的血管通路并发症是出血和肢体缺血。
评估置管技术、血管并发症的发生率及其对结果的影响。
对 2013 年至 2020 年期间接受 ECMO 治疗的 95 例患者进行回顾性数据分析。将患者分为两组:无血管通路并发症(非 VAC 组)和血管通路并发症(VAC 组)。比较两组患者的住院时间、入住 ICU 时间和输血情况。
两组患者在人口统计学和临床方面具有可比性。非 VAC 组有 75 例患者,VAC 组有 20 例患者。VAC 组观察到的主要并发症是置管部位出血,需要比非 VAC 组更多的输血(6.8 ± 1.02 比 4.2 ± 1.26)。肢体缺血是 VAC 组的另一个并发症(4.2%,n=4)。两名患者在拔管后出现迟发性出血。两组患者的平均住院时间在统计学上相似(VAC 组 22 天,非 VAC 组 18 天),但 VAC 组的平均 ICU 入住时间长于非 VAC 组(18 天比 12.06 天)。
出血和肢体缺血是重要的血管通路部位并发症,增加了输血需求、入住 ICU 时间和总住院时间。